These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 3101618)
1. Natural and concanavalin A-induced cytotoxic activity towards continuously growing B lymphocytes derived from patients with cutaneous T-cell lymphoma. Jensen JR; Kaltoft K; Bisballe S; Thestrup-Pedersen K Arch Dermatol Res; 1986; 279(1):12-5. PubMed ID: 3101618 [TBL] [Abstract][Full Text] [Related]
2. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome. Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128 [TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969 [TBL] [Abstract][Full Text] [Related]
4. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides. Haynes BF; Bunn P; Mann D; Thomas C; Eisenbarth GS; Minna J; Fauci AS J Clin Invest; 1981 Feb; 67(2):523-30. PubMed ID: 6970206 [TBL] [Abstract][Full Text] [Related]
5. Locomotion of T cells from patients with cutaneous T-cell lymphoma (Sézary syndrome and mycosis fungoides). Gupta S; Safai B; Edelson R; Parrott D; Good R Cell Immunol; 1980 Mar; 50(1):195-201. PubMed ID: 6967357 [No Abstract] [Full Text] [Related]
6. [Sézary syndrome. Clinical, immunological and proliferative kinetics]. Marosi L; Hofer F; Schwarzmeier J; Konrad K; Knapp W; Radaskiewicz T Acta Med Austriaca; 1979; 6(5):237-40. PubMed ID: 318012 [TBL] [Abstract][Full Text] [Related]
7. The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells. Bernengo MG; Novelli M; Quaglino P; Lisa F; De Matteis A; Savoia P; Cappello N; Fierro MT Br J Dermatol; 2001 Jan; 144(1):125-35. PubMed ID: 11167693 [TBL] [Abstract][Full Text] [Related]
9. Increased serum immunoglobulin levels are common in mycosis fungoides and Sézary syndrome. Talpur R; Lifshitz O; Breuer-Mcham J; Duvic M J Am Acad Dermatol; 2002 Nov; 47(5):685-91. PubMed ID: 12399759 [TBL] [Abstract][Full Text] [Related]
10. Killer cell immunoglobulin-like receptor expression delineates in situ Sézary syndrome lymphocytes. Wechsler J; Bagot M; Nikolova M; Parolini S; Martin-Garcia N; Boumsell L; Moretta A; Bensussan A J Pathol; 2003 Jan; 199(1):77-83. PubMed ID: 12474229 [TBL] [Abstract][Full Text] [Related]
11. Dysregulated synthesis of intracellular type 1 and type 2 cytokines by T cells of patients with cutaneous T-cell lymphoma. Lee BN; Duvic M; Tang CK; Bueso-Ramos C; Estrov Z; Reuben JM Clin Diagn Lab Immunol; 1999 Jan; 6(1):79-84. PubMed ID: 9874668 [TBL] [Abstract][Full Text] [Related]
12. Establishment of T and B cell lines from patients with mycosis fungoides. Kaltoft K; Thestrup-Pedersen K; Jensen JR; Bisballe S; Zachariae H Br J Dermatol; 1984 Sep; 111(3):303-8. PubMed ID: 6089859 [TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions. Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970 [TBL] [Abstract][Full Text] [Related]